Variant report
Variant | esv1000585 |
---|---|
Chromosome Location | chr4:82299388-82302779 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr4:82296919..82298708-chr4:82299908..82301828,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs113097909 | chr4:82299389-82299390 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs546014022 | chr4:82299459-82299460 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565685505 | chr4:82299488-82299489 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs62303573 | chr4:82299527-82299528 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs557559810 | chr4:82299546-82299547 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs577712533 | chr4:82299549-82299550 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs77384218 | chr4:82299550-82299551 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs76432166 | chr4:82299552-82299553 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs531377517 | chr4:82299613-82299614 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs190595508 | chr4:82299624-82299625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182883849 | chr4:82299647-82299648 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187186842 | chr4:82299664-82299665 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs1551236 | chr4:82299687-82299688 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs150995630 | chr4:82299691-82299692 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs192178462 | chr4:82299746-82299747 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs541454199 | chr4:82299754-82299755 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564403203 | chr4:82299767-82299768 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs386676578 | chr4:82299778-82299779 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs34165514 | chr4:82299815-82299816 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs533502891 | chr4:82299894-82299895 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs549676124 | chr4:82299903-82299904 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs76600404 | chr4:82299975-82299976 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs182636157 | chr4:82300012-82300013 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs115554501 | chr4:82300053-82300054 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs566021948 | chr4:82300074-82300075 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs528073051 | chr4:82300075-82300076 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs140830271 | chr4:82300082-82300083 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs187806566 | chr4:82300085-82300086 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs190216726 | chr4:82300090-82300091 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs556449480 | chr4:82300123-82300124 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs569918393 | chr4:82300124-82300125 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs182527063 | chr4:82300216-82300217 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs555629299 | chr4:82300284-82300285 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs546673135 | chr4:82300288-82300289 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs76226842 | chr4:82300329-82300330 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs35302859 | chr4:82300334-82300335 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs187519411 | chr4:82300363-82300364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs558149196 | chr4:82300376-82300377 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs371017507 | chr4:82300378-82300379 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs374219130 | chr4:82300531-82300532 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs538945063 | chr4:82300560-82300561 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs578013036 | chr4:82300562-82300563 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs374821513 | chr4:82300619-82300620 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs563436051 | chr4:82300624-82300625 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529091578 | chr4:82300689-82300690 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs559170213 | chr4:82300738-82300739 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs150129507 | chr4:82300751-82300752 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs138476881 | chr4:82300776-82300777 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs551053113 | chr4:82300789-82300790 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs141199788 | chr4:82300798-82300799 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Glioblastoma multiforme | 21922591 | CNVD |
Parkinson disease | 21956041 | CNVD |
Mental retardation | 20522426 | CNVD |
delayed speech | 20522426 | CNVD |
growth disorder | 20522426 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Parkinson disease | 18923514 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Follicular lymphoma | 17170743 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Autism | 18414403 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Gastric cancer | 16891809 | CNVD |
Prostate cancer | 16573809 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
abnormal development | 18461090 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:82297200-82303000 | Enhancers | Fetal Intestine Small | intestine |
2 | chr4:82297800-82302800 | Enhancers | Fetal Intestine Large | intestine |
3 | chr4:82298000-82300600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
4 | chr4:82298400-82299800 | Enhancers | Fetal Lung | lung |
5 | chr4:82298600-82300400 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
6 | chr4:82299200-82300600 | Enhancers | Fetal Kidney | kidney |
7 | chr4:82299200-82300800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
8 | chr4:82299400-82300000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr4:82299400-82300000 | Enhancers | NHDF-Ad | bronchial |
10 | chr4:82299800-82301000 | Weak transcription | Fetal Lung | lung |
11 | chr4:82300000-82301000 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr4:82300400-82300600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr4:82300600-82301000 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
14 | chr4:82300600-82301000 | Weak transcription | Fetal Kidney | kidney |
15 | chr4:82300800-82301200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
16 | chr4:82301000-82301600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
17 | chr4:82301000-82301800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
18 | chr4:82301000-82301800 | Enhancers | Fetal Heart | heart |
19 | chr4:82301000-82301800 | Enhancers | Fetal Kidney | kidney |
20 | chr4:82301000-82301800 | Enhancers | Stomach Mucosa | stomach |
21 | chr4:82301200-82301400 | Enhancers | Fetal Lung | lung |
22 | chr4:82301200-82302000 | Enhancers | Pancreatic Islets | Pancreatic Islet |
23 | chr4:82301200-82302800 | Enhancers | Duodenum Mucosa | Duodenum |